Surveillance and feedback of infection rates to clinicians and other stakeholders is a cornerstone of healthcare-associated infection (HAI) prevention programs. In addition, HAIs are increasingly included in public reporting and payment mandates. Conventional manual surveillance methods are resource intensive and lack standardization. Developments in information technology have propelled a movement toward the use of standardized and semiautomated methods. When developing automated surveillance systems, several strategies can be chosen with regard to the degree of automation and standardization and the definitions used. Yet, the advantages of highly standardized surveillance may come at the price of decreased clinical relevance and limited preventability. The choice among (automated) surveillance approaches, therefore, should be guided by the intended aim and scale of surveillance (eg, research, in-hospital quality improvement, national surveillance, or pay-for-performance mandates), as this choice dictates subsequent methods, important performance characteristics, and suitability of the data generated for the different applications.
The burden of healthcare-associated infections (HAIs) is considerable. Six percent of patients hospitalized in European hospitals are affected by an HAI on any given day, translating to approximately 2.6 million infections annually. A similar prevalence of 4.0% has been reported in the United States. Surgical site infections (SSIs), central line-associated bloodstream infections (CLABSI), urinary tract infections, and pneumonia account for the majority of cases [1, 2] . Prevention and surveillance of HAIs has received growing attention in recent years, propelled by an increased awareness of patient safety and avoidance of potentially preventable harm [3, 4] . HAIs are considered preventable complications of medical care and are increasingly included in pay-for-performance and public reporting mandates [5, 6] .
Achieving optimal prevention of HAIs requires considerable surveillance efforts; current manual surveillance methods are resource intensive and lack standardization. Developments in information technology (IT) have the potential to make regional or national surveillance programs feasible for a broad range of HAIs through full or partial automation [7] . Conversely, public reporting and payment mandates require performance characteristics from surveillance methods that differ from those of traditional in-hospital surveillance programs. As current surveillance systems must increasingly comply with public reporting mandates, with their necessary standardization, risk adjustment, and ranking requirements, attention must be placed on understanding the aims and methods of surveillance.
RATIONALE FOR SURVEILLANCE
Surveillance and feedback of infection rates to clinicians and other stakeholders has been a cornerstone of quality improvement in HAI prevention programs since the publication of the Study on the Efficacy of Nosocomial Infection Control [8] . The US Centers for Disease Control and Prevention's National Nosocomial Infection Surveillance Network and its successor the National Healthcare Safety Network provide de-identified national HAI data for benchmarking of local rates [9] . Numerous studies have validated similar approaches, and many countries have organized HAI surveillance networks such as the PREventie van ZIEkenhuisinfecties door Surveillance initiative in the Netherlands and the German Krankenhaus Infektions Surveillance System [10] [11] [12] .
In addition to local quality monitoring for stimulating and evaluating preventive interventions, these networks provide standardized surveillance methodology, aggregate data from participating hospitals, and provide benchmarking information for voluntary and confidential feedback to facilitate caregivers, hospitals, and policy makers in the interpretation of HAI rates [13, 14] . Successful quality improvement programs require accurate and reproducible data regarding the occurrence of HAIs and tools to assess the effect of interventions. Hence, measuring the incidence of HAIs provides essential data for action, and surveillance networks serve as a valuable framework for collecting and interpreting this data.
In traditional HAI surveillance, patient charts are manually reviewed by applying standardized case definitions to detect incident HAIs. This manual surveillance is time consuming and prone to error and subjective interpretation. Manual collection of clinical information suffers from the premise that "the more you look, the more you find" and limited interrater reliability when applying case definitions [15] [16] [17] [18] [19] . These characteristics of manual surveillance restrict its usefulness for interfacility comparison.
Automated surveillance methods have been recommended as a solution for the limitations of manual surveillance methods. Trick et al outlined how automation can improve the quality of decision making in surveillance [20] . In addition, electronic extraction of relevant data from electronic health records (EHRs) may address the "the more you look, the more you find" challenge [15] . Successful use of automation in surveillance using data stored in EHRs has been demonstrated for various types of HAIs, including SSIs and CLABSIs [21] . In addition, the use of automated algorithms for CLABSI surveillance has reduced interfacility variability compared to conventional manual surveillance [22] . The potential advantages of automation together with the increasing availability of EHRs have fueled the development of automated surveillance systems.
STANDARDIZATION OF SURVEILLANCE
In recent years, participation in surveillance networks has become mandatory or associated with payment incentives. In addition, public disclosure of HAI rates to inform providers, patients, and payers is increasingly advocated [9, 23] . Online public reporting of hospital HAI rates is now implemented in numerous countries [24] [25] [26] , and pay-for-performance programs impose financial penalties based on the occurrence of HAIs, for example, in the United States [27] . This increasing use of HAI surveillance systems to evaluate and reward quality is in keeping with patient safety initiatives that target other adverse events [28] .
The effect of public reporting and pay-for-performance mandates on the incidence of HAI is uncertain. Public reporting is hypothesized to lower HAI rates by both improving care processes and favoring patient choice toward high-performance institutions. However, whether these aims are achieved has not been unequivocally demonstrated [29] [30] [31] . Although reported rates of HAIs have decreased, it is unsure whether this reduction can be attributed to a true decline in HAI incidence. Sudden steep drops in HAI rates following the introduction of reporting or payment programs have been reported in several studies as have discrepancies between reported and not-reported HAI rates [32] [33] [34] [35] [36] . These observations have fed concerns regarding incentives for underreporting introduced by use of surveillance data in public reporting or payment programs [17] and illustrate that surveillance data may be vulnerable to Goodhart's law, which states that "any observed statistical regularity will tend to collapse once pressure is placed on it for control purposes" [37] .
Thus, if surveillance data are used for public reporting, surveillance methods must provide high-volume data with an acceptable degree of reliability and objectivity. Automation of surveillance may provide a solution for this challenge given its features of reproducibility, objectivity, and scalability. As we transition to increasingly automated surveillance methods, it is necessary to reevaluate whether our methods are in line with the aims of surveillance.
APPROACHING AUTOMATED SURVEILLANCE
Automated surveillance systems can be designed to either support or completely replace manual surveillance efforts, so-called semiautomated and fully automated surveillance systems, respectively ( Figure 1A and 1B) [38] .
In semiautomated surveillance, an algorithm selects patients with a high probability of HAI based on data stored in EHRs for subsequent manual confirmation of infection. Patients with a low probability of infection are assumed to not have developed an infection and are classified as "no HAI" without undergoing manual chart review. In fully automated systems, however, there is no manual assessment and a standardized definition is applied using the available electronic data.
Both approaches to automation require accurate and reliable routine care (clinical) data stored in EHRs with an adequate degree of standardization to allow for application of case definitions. This can be data collected for administrative purposes (eg, diagnosis codes used for billing) or for clinical care and includes demographic information, diagnostic test results, microbiology results, pharmacy records, and other clinical characteristics [39] . A distinction can also be made between data that directly represent what happened to the patient (eg, culture results, procedures) and data elements that rely on interpretation and documentation by clinicians, including diagnoses, clinical signs, and symptoms. Ensuring availability and accuracy of this data can be challenging irrespective of the approach chosen, and, in general, use of clinical data outperforms administrative data such as (coded) diagnoses [40] .
However, these 2 approaches to automated surveillance do have different features and performance characteristics (Table 1) . Semiautomated surveillance focuses on high sensitivity to detect possible HAIs to be confirmed by chart review. This implies that algorithms can be adapted to local circumstances and new insights, as long as they remain highly sensitive. Similar to traditional manual surveillance, semiautomated surveillance requires standardized consensus definitions that can be used for manual assessment. In contrast, in fully automated surveillance, there is no manual confirmation of infection, and definitions must be adapted such that in all settings where it is intended to be used, ascertainment of HAI is possible by using an algorithm that solely relies on data that is routinely documented in a structured format in EHRs. In most cases, this means that clinical signs and symptoms are not included in the definition, as this information is infrequently or poorly documented in structured fields [41] . As there is no manual interpretation step, the fully automated approach may achieve a higher degree of standardization by eliminating subjective interpretation. Chart review and manual ascertainment to confirm HAI cases are required in semiautomated surveillance, but the preselection of possible HAI cases eliminates some concerns with manual surveillance, as case finding is no longer effort dependent and the number of charts that require manual review is typically reduced by more than 75% [42] . In semiautomated surveillance, achieving high sensitivity is of greatest importance, as manual review will prevent misclassification of false-positive cases, whereas in fully automated surveillance, high specificity and positive predictive value to avoid false positives are the main performance criteria. Arguably, semiautomated surveillance with room for manual (human) interpretation may have more favorable clinician buy-in compared to fully automated surveillance. On the other hand, explicitly involving clinicians in the aims and methods of large-scale standardized surveillance may educate them on the advantages of fully automated surveillance. Despite its advantages, automation is complicated by limited access to the required clinical data and insufficient knowledge of automation within infection control [43] . In addition, interpretation and comparability are hindered by heterogeneity of the surveillance systems and EHRs currently being developed in hospitals and by commercial parties, both on a local and global scale. Closer collaboration between the healthcare epidemiology community and EHR developers can provide a crucial contribution toward equipping EHRs with the needed infrastructure for clinical data warehousing and follow-up of patients, standardize data elements to be recorded in fixed fields, and perhaps allow for surveillance methods to expand across networks of hospitals.
IS FULL AUTOMATION THE SOLUTION?
The increasing importance attributed to standardization of surveillance has resulted in adaptation of surveillance definitions in order to eliminate subjective interpretation and facilitate full automation [41] . These adaptations, however, may also be associated with unintended consequences.
The introduction of the ventilator-associated events (VAEs) algorithm in 2013 illustrates some of the side-effects of adopting definitions tailored for objective, fully automatable surveillance. VAEs are a set of nested conditions, defined by algorithms based on ventilator settings, antibiotic use, microbiology results, and objective clinical signs and symptoms that replaced conventional definitions for ventilator-associated pneumonia. The latter were considered suboptimal both for clinical and surveillance and reporting purposes [44] . Subjective interpretation was removed from case ascertainment, thereby facilitating automated surveillance.
On the flip side, the clinical events detected by the novel VAE paradigm are less specific and represent a broad scope of clinical conditions that range from fluid overload to pneumonia to neurological deterioration. This clinical breadth of events makes selection of specific, targeted interventions more difficult, and the idea of preventability of this automated outcome can be questioned. Recent studies have shown contradictory results regarding the effect of known preventive measures for conventional VAP on rates of events identified by the tiers of the VAE framework [45] [46] [47] . In addition, although full standardization resulted in more objective data, studies have shown that automation is not the silver bullet for preventing unwanted variation; small differences in implementation affect the outcome of surveillance, and the risk of gaming remains. Finally, the rapid introduction of new definitions precluded the generation of sufficient overlapping data to link historic data to current performance, and regular changes to algorithms limit comparison over time [44, 45, [48] [49] [50] . Simplified and automatable surveillance is now also considered for other HAI types such as using so-called hospital-onset bacteremia (HOB) for CLABSIs, although there is little data on the degree to which HOB events are amenable to prevention. It can be envisioned that such simplified measures may be associated with similar disadvantages of nonspecificity and inability to implement targeted interventions based on the rates generated [51, 52] .
Thus, converting to definitions that are compatible with full automation and hence no longer consider possibly ambiguous parameters (including clinical signs and symptoms) simplifies surveillance and can improve standardization. However, these definitions may be less suited for selecting the most appropriate, specific interventions, irrespective of whether the definitions are applied manually or electronically. In addition, these shifts may reduce acceptance by the medical community, thereby jeopardizing the value of surveillance in a quality improvement cycle (in other words, providing less data for action). In contrast, using conventional definitions in the setting of semiautomated surveillance may be less well suited for interfacility comparison.
From the perspective of hospital comparison, relying on fully automated quality metrics that target a broad range of clinical events hinders development of adequate risk-adjustment models, as the scope of underlying risk factors that must be adjusted for becomes equally broad. Risk adjustment, however, is an essential component to achieve valid interhospital comparisons [53] . In sum, it remains unclear whether transitioning to fully automated standardized surveillance using adapted definitions will help drive quality improvement cycles.
MOVING FORWARD
Converting to automated or semiautomated surveillance methods will advance the field toward improved surveillance systems, in particular, if an explicit choice is made regarding the method of automation. Addressing some of the mismatches in surveillance's aims and outcomes requires going back to Simon Sineks' "Golden Circle, " that is, what we measure depends on how we measure, which should depend on why we measure. Surveillance of HAIs should have a specified aim (the why) that determines what and how we measure and thereby defines performance characteristics. Table 2 lists some key characteristics of 4 possible aims of surveillance [54] . Explicit articulation of aims will also clarify how resulting surveillance data should be interpreted and used to, for example, improve quality of care or achieve interfacility comparison.
If one's aim is to prevent HAIs through quality improvement programs within hospitals, the surveillance method chosen should detect clinically relevant, preventable outcomes that can be compared over time and are accepted by the caregivers. In this perspective, the chart-review component of semiautomated surveillance may stimulate in-depth assessment of HAI cases, identification of care processes that lead to infection, and, importantly, ensure clinical ownership of infection rates. Manual adjudication may, however, introduce some interrater variability among healthcare facilities.
Yet, if one's aim is to generate data for public reporting and pay-for-performance mandates, fully automated surveillance systems will allow for standardized assessment of large numbers of patients. Importantly, these systems must be designed such that they are capable of identifying outliers and can provide valid data for interfacility comparison. However, it must be realized that imperfect standardization, inadequate risk adjustment, and gaming cannot be fully excluded. Also, if a measure has been designed as a fully automated standardized public reporting measure, it is important to appreciate that it is not necessarily suitable as a method to evaluate the effect of preventive measures. Conversely quality measures targeted at in-hospital quality improvement may not meet the performance requirements for interfacility comparison.
For future surveillance efforts, redesigning surveillance may require the use of 2 methods to meet the different aims of surveillance, namely, driving in-hospital quality improvement cycles and comparing rates across facilities, although some common ground can be envisioned between them. By their nature, some HAIs are more straightforward to identify than others. Focusing surveillance on the more severe infections (eg, deep SSIs) would still identify those patients with clinically relevant events and generate useful data for in-hospital quality improvement, while at the same time providing objective and efficient data for large-scale surveillance. For instance, assessing deep SSIs after hip or knee replacement surgery is often less obscured by clinical factors than surveillance of SSIs after colon surgery. In addition, detection of complex SSIs has better interrater reliability compared to superficial SSIs [55] . Hence, these clinically relevant outcomes collected to drive in-hospital quality improvement cycles may become suitable for larger-scale standardized surveillance. On the flip side, possible unwanted consequences of imposing public reporting or payment mandates on data collected for in-hospital quality improvement must be considered, as it may induce a hesitancy to report (and detect) these infections. This reluctance might subsequently compromise the value of in-hospital surveillance and prevention programs. We may need to accept that data on "subjective" infections are not suitable for large-scale standardization. Finally, surveillance systems that serve different purposes may need to exist next to each other in the future, although this places a higher burden on scarce resources available to healthcare facilities for surveillance.
Aside from explicitly defining targets and aims of surveillance, development of automated surveillance systems is also associated with challenges specific to the local, national, or international scale (Table 3) . Surveillance systems designed for local use in quality improvement programs can be customized to the possibilities and wishes of individual hospitals. On the national and international level, consensus regarding surveillance aims and methods will allow for national and international comparison of performance. Ideally, the scale on which surveillance is performed should be aligned with the predetermined aims of surveillance. Current development efforts of automated systems are characterized by high heterogeneity in aims and specifications and therefore also in the results obtained. In order to generate the much needed data on HAI incidence and perhaps expand surveillance beyond the single hospital, regaining consensus on aims and definitions is essential. To maximize local quality improvement cycles, a focus on clinical relevance, preventability, and acceptance of the definitions chosen will contribute to reaching clinical buy-in. In the setting of large-scale national or international standardization, consensus on definitions and methods for automated surveillance used is vital. For both applications, setting shared minimal performance standards will increase the quality of surveillance efforts and allow surveillance networks to work with EHR manufacturers to develop high-quality IT solutions.
CONCLUSIONS
In sum, automated surveillance of HAIs has the potential to improve quality and efficiency of surveillance efforts. These developments and the increasing importance of public reporting force us to go back to the drawing board. The first step in redeveloping surveillance of HAIs should be an explicit definition of the aims of surveillance, as this will dictate the most appropriate approaches to (automated) surveillance and define what performance characteristics are important when designing or selecting a system. Developing semiautomated surveillance based on definitions that include clinical data elements may provide actionable data for quality improvement but has limitations with regard to interfacility comparison. Fully automated surveillance may address these challenges at the cost of clinical ownership and the ability to drive quality improvement. In addition, the implementation of automated surveillance systems in practice is complicated by practical challenges regarding the availability of high-quality data, EHR standardization, and specialized IT and infection control personnel. Addressing these challenges will ensure that HAI surveillance continues to provide the medical community with the data it needs.
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